JPRN-UMIN000004141已完成未知
Darbepoetin alpha for anemia in patients with chronic hepatitis C treated with combination therapy of peginterferon alpha-2b plus ribavirin - Darbepoetin for ribavirin-induced anemia in chronic hepatitis C patients
Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences0 个研究点目标入组 21 人开始时间: 2010年9月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 21
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 70years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1. Allergic to peginterferon alpha-2b or other interferon preparations. 2. Allergic to vaccine or biological preparations. 3. Allergic to ribavirin or other nucleoside analogue preparations. 4. Pregnant or under breast feeding. 5. Uncontrolled cardiovascular diseases. 6. Abnormal hemoglobinemia. 7. Chronic renal failure or creatinine clearance value less than 50 mL/min. 8. Severe depression or psychiatric disorders including a history of a suicide attempt. 9. Severe or decompensated liver disease. 10. Vascular diseases of central nervous system. 11. Autoimmune liver diseases. 12. Concomitant herbal medication such as Sho-saiko-to. 13. Allergic to darbepoetin alpha or other erythropoietin preparations. 14. Other conditions considered inappropriate by attending physician.
研究者
相似试验
已完成
不适用
The effect of Darbepoetin for renal anemia and iron kinetics in Chronic Kidney Disease(CKD) patientsChronic kidney disease and renal anemiaJPRN-UMIN000005068Yamamoto General Hospital20
招募中
1 期
Efficacy of D-alanine intake in patients with chronic kidney disease; a randomized controlled pilot trialChronic kidney diseaseJPRN-jRCTs041230148Oshima Megumi24
已完成
不适用
The effect of alpha-defensin on patients with chronic pancreatitisChronic pancreatitisJPRN-UMIN000030207Hokkaido University Hospital100
进行中（未招募）
不适用
Traitement par érythropoïétine de l'anémie associée à la bronchopneumopathie chronique obstructive : conséquences fonctionnelles à l'effort - ELABAnémie associée à la BPCOMedDRA version: 8.1Level: PTClassification code 10009033Term: chronic obstructive pulmonary diseaseEUCTR2007-003153-90-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
已完成
2 期
A Study of Darbepoetin Alfa in Anemic Subjects With Low Risk Myelodysplastic SyndromeMyelodysplastic SyndromesNCT00095264Amgen209